Assessment Protocol: Participants will undergo a series of non-invasive assessments including the Figure-of-8 Walk Test (8FWT) and Timed Up and Go (TUG) test to evaluate gait performance, dynamic balance, and cognitive-motor interaction. No therapeutic intervention will be applied.
Study summary
This observational study aims to investigate the validity and reliability of the Figure-of-8 Walk Test (8FWT) in individuals with Motoric Cognitive Risk Syndrome (MCRS). The study will evaluate test-retest reliability, measurement error (SEM, MDC), and construct validity by examining the relationship between 8FWT performance and functional mobility measures. The findings are expected to provide evidence for the clinical applicability of 8FWT in assessing dynamic balance, gait performance, and cognitive-motor interaction in older adults.
Eligibility
Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
Aged 65 years or older Presence of subjective cognitive complaints Gait speed ≤ 0.8 m/s (4-meter walk test) Able to walk independently without assistive devices No clinical diagnosis of dementia Able to understand and follow test instructions
Exclusion Criteria:
Mini-Mental State Examination (MMSE) score \< 24 Neurological diseases affecting gait (e.g., stroke, Parkinson's disease, multiple sclerosis) Severe musculoskeletal conditions affecting walking Lower extremity surgery within the last 6 months Severe visual or hearing impairment that interferes with testing Dependence on assistive walking devices
Primary outcome measure(s)
Figure-of-8 Walk Test completion time — Baseline Time required to complete the Figure-of-8 Walk Test will be recorded in seconds.
Figure-of-8 Walk Test number of steps — Baseline The number of steps taken during the Figure-of-8 Walk Test will be recorded.
Figure-of-8 Walk Test walking speed — Baseline Walking speed during the Figure-of-8 Walk Test will be calculated in meters per second.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.